NYSE · Healthcare · Medical Devices · USA
Zimmer Biomet Holdings Inc is a large cap company (market value between $10 billion and $200 billion) in the Medical Devices industry.
Zimmer Biomet designs, manufactures and markets orthopedic reconstructive products, sports medicine and trauma solutions, craniomaxillofacial products, bone cement, and integrated digital and robotic technologies. The company serves orthopedic surgeons, neurosurgeons and healthcare institutions across the Americas, Europe Middle East and Africa, and Asia Pacific, addressing disorders and injuries affecting bones, joints and supporting soft tissues.
From its FY2025 annual report (Form 10-K)
Intrinsic value, DCF valuation, financial health and value investing analysis for the Zimmer Biomet Holdings Inc stock.
Undervalued: intrinsic value $148.88 per share, market price $94.99, margin of safety 36.2% (as of 2026-10-19).
Discounting its cash flows at 7.6% (average of 3 methods) values the shares at $148.88; the price of $94.99 is 36% below that value, and 81% of that value comes from beyond year five.
Leak Score: 69/100 on 12 of 12 signals (Faint Leak).
17 more funds hold it; the full list is part of the paid plan.
All 142 Medical Devices stocks
1 more in this industry show a wider margin of safety.
ZBH is undervalued (as of the 2026-10-19 close). Discounting its cash flows at 7.6% (average of 3 methods) values the shares at $148.88; the price of $94.99 is 36% below that value, and 81% of that value comes from beyond year five.
$148.88 per share (as of the 2026-10-19 close), against a market price of $94.99. That is a margin of safety of 36.2%. The value is the average of the valuation methods that apply to this company, recomputed every night after the US close.
69 out of 100, which we rate "Faint Leak", on 12 of 12 value investing signals.